Androgen/androgen receptor (AR) signaling plays decisive roles in testicular spermatogenesis [1] . However, the underlying molecular mechanism of androgen and AR regulation (i.e. the genes that are regulated and their functions) remains largely undefined. Microarray analysis combined with androgen treatment or AR knockout animal models has identified androgen-dependent genes in mouse testis [2, 3] . However, this approach does not distinguish direct and indirect targets of androgen/AR. Until now, only a few AR-binding sites containing androgen responsive elements (AREs) located within the promoter regions of androgen responsive genes in testis have been reported, implying that these genes are direct targets of AR. These genes include kallikrein 27 (Klk27) [4] , reproductive homeobox 5 (Rhox5) [5] , epididymal peptidase inhibitor (Eppin) [6] , and cytochrome P450, family 17, subfamily a, polypeptide 1 (Cyp17) [7] . All of these binding events were demonstrated using in vitro assays including electrophoretic mobility shift assays (EMSA), deoxyribonuclease I footprinting, and luciferase assays. However, these in vitro measurements cannot be easily extrapolated into in vivo mechanisms, as mammalian genes are commonly organized into broad chromosomal domains, and such domains cannot be readily reconstituted in vitro. Thus the in vivo assays are greatly required for measuring AR-DNA interactions in testis and understanding the physiological transcriptional mechanisms. Until now, only one AR-binding site associated with tubulin, beta 3 class III (Tubb3) gene was identified in mouse testis in vivo using chromatin immunoprecipitation (ChIP) [8] .
ChIP is a powerful and widely used technique for probing protein -DNA interactions within the natural chromatin context of the cell. In the present study, we demonstrated AR regulation on Klk27, Rhox5, Eppin, and Cyp17 genes in adult mouse testis using ChIP assays.
We first tested whether two widely used AR antibodies (H-280 and N-20; Santa Cruz, Santa Cruz, USA) could specifically immunoprecipitate AR in mouse testis. The results showed that both of them specifically immunoprecipitated a single band at 110 kDa from nuclear extracts of testis [ Fig. 1 (A)]; this band was not observed in control experiments using normal rabbit immunoglobulin G (IgG) (Santa Cruz).
We then tested whether the antibodies could be used for ChIP in testis. The finely minced testis tissues were formaldehyde cross-linked to preserve protein-DNA complexes, and nuclear extracts were prepared. The chromatin was sheared by sonication, yielding DNA fragments 300 bp in length [ Fig. 1(B) ], and the AR-DNA complexes were immunoselected with the anti-AR antibody. After reversal of the cross-links and DNA purification, polymerase chain reaction (PCR), or real time-PCR was used to detect the AR binding to specific sites.
An AR-binding site located in the intron region of Tubb3 has been identified in mouse testis using ChIP, but the site only showed very weak enrichment of AR [8] . Our previous ChIP-seq assays performed in mouse caput epididymis have identified genome wide AR-binding sites [9] . Since the close correlation in structure and function between testis and caput epididymis, we hypothesized that some AR-binding sites in caput epididymis would be also be occupied by AR in testis. Ten classical AR-binding sites identified in caput epididymis were selected, and AR occupancies in testis were confirmed by ChIP-PCR. As shown in Fig. 1(C) , four binding sites that included two miRNA-associated sites were enriched, indicating AR binding in testis. Thus, the AR antibody specifically immunoprecipitated its associated DNA in testis.
Next, we verified the reported AR-binding sites which were identified in vitro by ChIP analysis. A group of nine known AREs at six genomic loci from the literature was summarized in Table 1 . The AR occupancies on these sites were confirmed by ChIP-PCR and ChIP-quantitative PCR (qPCR). Fold enrichment calculated using IgG enrichment as a control was used to normalize ChIP-qPCR data. As shown in Fig. 2 , the fold enrichment of AR-binding site associated with Tubb3 was only 2.19, indicating weak enrichment of AR on this site, which was identical to the previous results. Among other five sites identified in vitro, only one associated with Eppin was enriched and four sites associated with Rhox5, Klk27, and Cyp17 were not enriched, indicating no AR binding. This result suggested that some AR-binding sites previously identified in vitro were not bound by AR in the adult mouse testis in vivo.
These data demonstrated that Eppin is a direct target gene of AR in testis, but Rhox5, Klk27, and Cyp17 genes may be indirect target genes of AR or directly controlled by AR via binding sites far from promoters. Indeed, recent studies have shown that AR-binding sites in genome are mainly localized in the intronic and intergenic regions [10] . The development of ChIP assays to measure AR-DNA interactions in testis will greatly facilitate progress in understanding physiological transcriptional mechanisms of AR during spermatogenesis.
In this study, ChIP-PCR results demonstrated that some epididymal AR-binding sites were enriched in testis, but others were not. The enriched sites were associated with genes (Fkbp5 and caveolin-1) and miRNAs (Mir-29 and Mir-21) which were widely expressed and played general functions in different tissues. The non-enriched-siteassociated genes (Serpina1f, Car2, Adam7, and Ptgds) showed epididymis-predominant expression pattern and might play essential roles in sperm maturation. Our data provided preliminary molecular data for tissue-selective binding of AR.
Given the complexities of in vivo transcriptional regulations, large-scale studies, for example, ChIP-on-chip or ChIP-seq will be needed to finally clarify the AR regulation network in testis. Figure 2 Validation of known AR-binding sites associated with genes Eppin, Rhox5, Klk27 and Cyp17 by ChIP-PCR (A) or ChIP-qPCR (B) using anti-AR antibody (H-280) in mouse testis Enrichment folds were calculated using IgG enrichment as a control. The data are presented as the mean + standard deviation of three replicates.
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